{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:16:14Z","timestamp":1793301374837,"version":"4.5.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.phrs.2025.107638","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:17:32Z","timestamp":1738225052000},"page":"107638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["From bench to bedside: Developing CRISPR\/Cas-based therapy for ocular diseases"],"prefix":"10.1016","volume":"213","author":[{"given":"Qing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107638_bib1","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Vision loss expert group of the global burden of disease study, trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.phrs.2025.107638_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.addr.2020.06.011","article-title":"Ocular delivery of CRISPR\/Cas genome editing components for treatment of eye diseases","volume":"168","author":"Yu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2025.107638_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41577-024-01064-y","article-title":"Redefining our vision: an updated guide to the ocular immune system","volume":"24","author":"Wu","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.107638_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107638_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107638_bib7","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290-associated retinal degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2025.107638_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.preteyeres.2018.03.003","article-title":"CRISPR-Cas9 genome engineering: treating inherited retinal degeneration","volume":"65","author":"Burnight","year":"2018","journal-title":"Prog. Retin Eye Res"},{"key":"10.1016\/j.phrs.2025.107638_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100975","article-title":"Early and late stage gene therapy interventions for inherited retinal degenerations","volume":"86","author":"Botto","year":"2022","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.omtm.2023.05.020","article-title":"Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6","volume":"30","author":"Mellen","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2025.107638_bib11","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1177\/15353702231199069","article-title":"CRISPR\/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model","volume":"248","author":"Du","year":"2023","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.phrs.2025.107638_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107638_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2019.100789","article-title":"Sharpening the molecular scissors: advances in gene-editing technology","volume":"23","author":"Broeders","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.phrs.2025.107638_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s10038-017-0352-4","article-title":"In vivo genome editing via the HITI method as a tool for gene therapy","volume":"63","author":"Suzuki","year":"2018","journal-title":"J. Hum. Genet"},{"key":"10.1016\/j.phrs.2025.107638_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/APO.0000000000000209","article-title":"Genetics of Bietti crystalline dystrophy","volume":"5","author":"Ng","year":"2016","journal-title":"Asia Pac. J. Ophthalmol. (Philos."},{"key":"10.1016\/j.phrs.2025.107638_bib16","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1038\/s41467-024-48092-9","article-title":"In vivo genome editing via CRISPR\/Cas9-mediated homology-independent targeted integration for Bietti crystalline corneoretinal dystrophy treatment","volume":"15","author":"Meng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107638_bib18","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.3390\/ijms241914865","article-title":"CRISPR\/dCas9 tools: epigenetic mechanism and application in gene transcriptional regulation","volume":"24","author":"Cai","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123120","article-title":"CRISPR innovations in tissue engineering and gene editing","volume":"358","author":"Razavi","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2020.6418","article-title":"Analysis of pathogenic variants correctable with CRISPR base editing among patients with recessive inherited retinal degeneration","volume":"139","author":"Fry","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.phrs.2025.107638_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107638_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101132","article-title":"In vivo application of base and prime editing to treat inherited retinal diseases","volume":"94","author":"Jo","year":"2023","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-031-27681-1_16","article-title":"Analysis of CRB1 pathogenic variants correctable with CRISPR base and prime editing","volume":"1415","author":"da Costa","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2025.107638_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101289","article-title":"Genetic therapies and potential therapeutic applications of CRISPR activators in the eye","volume":"102","author":"Ng","year":"2024","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib25","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3390\/ijms21072329","article-title":"CRISPR interference-potential application in retinal disease","volume":"21","author":"Peddle","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.62.12.7","article-title":"Using CRISPR interference as a therapeutic approach to treat TGF\u03b22-induced ocular hypertension and glaucoma","volume":"62","author":"Rayana","year":"2021","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/crispr.2023.0065","article-title":"Rapid variant pathogenicity analysis by CRISPR activation of CRB1 gene expression in patient-derived fibroblasts","volume":"7","author":"Moon","year":"2024","journal-title":"Crispr J."},{"key":"10.1016\/j.phrs.2025.107638_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5614","article-title":"A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation","volume":"6","author":"B\u00f6hm","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2025.107638_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2017.06.050","article-title":"The molecular architecture for RNA-guided RNA cleavage by Cas13a","volume":"170","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107638_bib30","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/s41467-019-10507-3","article-title":"Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108317","article-title":"Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases","volume":"213","author":"Bigini","year":"2023","journal-title":"Vis. Res"},{"key":"10.1016\/j.phrs.2025.107638_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molmed.2018.06.006","article-title":"Seeing the light after 25 years of retinal gene therapy","volume":"24","author":"Trapani","year":"2018","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jtos.2024.09.010","article-title":"Preventing and treating neurotrophic keratopathy by a single intrastromal injection of AAV-mediated gene therapy","volume":"34","author":"Cong","year":"2024","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.phrs.2025.107638_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2337\/db24-0393","article-title":"Long-term nerve regeneration in diabetic keratopathy mediated by a novel NGF delivery system","volume":"74","author":"Cong","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2025.107638_bib35","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.ymthe.2023.08.021","article-title":"In vivo CRISPR gene editing in patients with herpetic stromal keratitis","volume":"31","author":"Wei","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib36","article-title":"Genome editing VEGFA prevents corneal neovascularization in vivo","volume":"11","author":"Zeng","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2025.107638_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/nat.2019.0838","article-title":"Delivery of antisense oligonucleotides to the cornea","volume":"30","author":"Chau","year":"2020","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.omtm.2019.06.009","article-title":"Transduction pattern of AAVs in the trabecular meshwork and anterior-segment structures in a rat model of ocular hypertension","volume":"14","author":"Lee","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2025.107638_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.63.13.15","article-title":"Intracameral injection of AAV-DJ.COMP-ANG1 reduces the IOP of mice by reshaping the trabecular outflow pathway","volume":"63","author":"Qiao","year":"2022","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib40","first-page":"7","article-title":"Downregulation of SARM1 protects retinal ganglion cell axonal and somal degeneration via JNK activation in a glaucomatous model of ocular hypertension","volume":"65","author":"Zhang","year":"2024","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9","volume":"28","author":"Wu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: Progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.107638_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-based therapeutic genome editing: Strategies and in vivo delivery by AAV vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107638_bib46","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.3390\/ijms22137234","article-title":"The Lrat(-\/-) rat: CRISPR\/Cas9 construction and phenotyping of a new animal model for retinitis pigmentosa","volume":"22","author":"Koster","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib47","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1038\/s41467-022-35361-8","article-title":"Gene augmentation prevents retinal degeneration in a CRISPR\/Cas9-based mouse model of PRPF31 retinitis pigmentosa","volume":"13","author":"Xi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121598","article-title":"Generation and characterization of a zebrafish model for ADGRV1-associated retinal dysfunction using CRISPR\/Cas9 genome editing technology","volume":"12","author":"Stemerdink","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107638_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00441-022-03702-0","article-title":"The medaka mutant deficient in eyes shut homolog exhibits opsin transport defects and enhanced autophagy in retinal photoreceptors","volume":"391","author":"Sato","year":"2023","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.phrs.2025.107638_bib50","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.bbadis.2019.07.009","article-title":"Knocking out lca5 in zebrafish causes cone-rod dystrophy due to impaired outer segment protein trafficking","volume":"1865","author":"Qu","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2025.107638_bib51","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.3390\/ijms22168863","article-title":"Involvement of oxidative and endoplasmic reticulum stress in RDH12-related retinopathies","volume":"22","author":"Sarkar","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/tvst.12.2.26","article-title":"USH2A gene mutations in rabbits lead to progressive retinal degeneration and hearing loss","volume":"12","author":"Nguyen","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.phrs.2025.107638_bib53","doi-asserted-by":"crossref","first-page":"Bio34","DOI":"10.1167\/iovs.16-21287","article-title":"CRISPR\/Cas9-mediated mutation of \u03b1A-crystallin gene induces congenital cataracts in rabbits","volume":"58","author":"Yuan","year":"2017","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11427-023-2364-3","article-title":"The role of corneal endothelium in macular corneal dystrophy development and recurrence","volume":"67","author":"Zhang","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib55","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41598-020-58876-w","article-title":"Generation of mouse model of TGFBI-R124C corneal dystrophy using CRISPR\/Cas9-mediated homology-directed repair","volume":"10","author":"Kitamoto","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41419-022-04836-3","article-title":"Age-related visual impairments and retinal ganglion cells axonal degeneration in a mouse model harboring OPTN (E50K) mutation","volume":"13","author":"Hou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107638_bib57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41419-023-06086-3","article-title":"Autophagy deficiency protects against ocular hypertension and neurodegeneration in experimental and spontanous glaucoma mouse models","volume":"14","author":"Dixon","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107638_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.stemcr.2020.05.007","article-title":"Modeling and rescue of RP2 retinitis pigmentosa using iPSC-derived retinal organoids","volume":"15","author":"Lane","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib59","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.stemcr.2022.08.005","article-title":"Investigation of PTC124-mediated translational readthrough in a retinal organoid model of AIPL1-associated Leber congenital amaurosis","volume":"17","author":"Leung","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib60","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.3390\/ijms24065912","article-title":"Retinal organoids from an AIPL1 CRISPR\/Cas9 knockout cell line successfully recapitulate the molecular features of LCA4 disease","volume":"24","author":"Perdig\u00e3o","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215005120","article-title":"CRISPR editing demonstrates rs10490924 raised oxidative stress in iPSC-derived retinal cells from patients with ARMS2\/HTRA1-related AMD","volume":"120","author":"Chang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107638_bib62","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.3390\/ijms24043417","article-title":"Development of a CRISPRi human retinal pigmented epithelium model for functional study of age-related macular degeneration genes","volume":"24","author":"Wang","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.61.2.9","article-title":"Increased rate of retinal pigment epithelial cell migration and pro-angiogenic potential ensuing from reduced cystatin C expression","volume":"61","author":"Carlsson","year":"2020","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41419-024-06762-y","article-title":"PGC-1\u03b1 repression dysregulates lipid metabolism and induces lipid droplet accumulation in retinal pigment epithelium","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107638_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100504","article-title":"Deep learning-based identification of intraocular pressure-associated genes influencing trabecular meshwork cell morphology","volume":"4","author":"Greatbatch","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib66","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/MOP.0000000000000690","article-title":"Retinitis pigmentosa: recent advances and future directions in diagnosis and management","volume":"30","author":"Fahim","year":"2018","journal-title":"Curr. Opin. Pedia"},{"key":"10.1016\/j.phrs.2025.107638_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib68","article-title":"CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa","volume":"5","author":"Nolan","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phrs.2025.107638_bib69","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/pharmaceutics14040824","article-title":"AAV-CRISPR\/Cas9 gene editing preserves long-term vision in the P23H rat model of autosomal dominant retinitis pigmentosa","volume":"14","author":"Shahin","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2025.107638_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84065","article-title":"Allele-specific gene-editing approach for vision loss restoration in RHO-associated retinitis pigmentosa","volume":"12","author":"Liu","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2025.107638_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2021.01.006","article-title":"Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model","volume":"108","author":"Patrizi","year":"2021","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.phrs.2025.107638_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/hum.2023.201","article-title":"Knockout and replacement gene surgery to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa","volume":"35","author":"Sun","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib73","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.omtn.2023.08.002","article-title":"Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice","volume":"33","author":"Yan","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib74","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1089\/crispr.2023.0039","article-title":"CRISPRi-mediated treatment of dominant rhodopsin-associated retinitis pigmentosa","volume":"6","author":"Burnight","year":"2023","journal-title":"Crispr J."},{"key":"10.1016\/j.phrs.2025.107638_bib75","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/ijms22052607","article-title":"Allele-specific knockout by CRISPR\/Cas to treat autosomal dominant retinitis pigmentosa caused by the G56R mutation in NR2E3","volume":"22","author":"Diakatou","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib76","article-title":"Therapeutic in vivo gene editing achieved by a hypercompact CRISPR-Cas12f1 system delivered with all-in-one adeno-associated virus","volume":"11","author":"Cui","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2025.107638_bib77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41434-021-00258-6","article-title":"Restoration of RPGR expression in vivo using CRISPR\/Cas9 gene editing","volume":"29","author":"Gumerson","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib78","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijms22042092","article-title":"Gene correction recovers phagocytosis in retinal pigment epithelium derived from retinitis pigmentosa-human-induced pluripotent stem cells","volume":"22","author":"Artero-Castro","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib79","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-3-031-27681-1_83","article-title":"Generation of CRB1 RP patient-derived iPSCs and a CRISPR\/Cas9-mediated homology-directed repair strategy for the CRB1c.2480G>T mutation","volume":"1415","author":"da Costa","year":"2023","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.phrs.2025.107638_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav3335","article-title":"In vivo genome editing rescues photoreceptor degeneration via a Cas9\/RecA-mediated homology-directed repair pathway","volume":"5","author":"Cai","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2025.107638_bib81","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bjophthalmol-2016-309975","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions","volume":"101","author":"Kumaran","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.phrs.2025.107638_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101244","volume":"100","author":"Georgiou","year":"2024","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib83","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.stemcr.2021.09.007","article-title":"Allele-specific gene editing to rescue dominant CRX-associated LCA7 phenotypes in a retinal organoid model","volume":"16","author":"Chirco","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib84","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.omtm.2023.05.012","article-title":"CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids","volume":"29","author":"Afanasyeva","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2025.107638_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1210","article-title":"CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis","volume":"5","author":"Jo","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2025.107638_bib86","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/s41467-024-49233-w","article-title":"PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics","volume":"15","author":"Acharya","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171356","article-title":"Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy","volume":"133","author":"Kabra","year":"2023","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107638_bib88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.omtn.2022.11.021","article-title":"Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing","volume":"31","author":"Jo","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cell.2018.03.021","article-title":"Gene therapy for retinal degeneration","volume":"173","author":"Apte","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107638_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib91","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbadis.2014.11.020","article-title":"Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities","volume":"1852","author":"Mathur","year":"2015","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2025.107638_bib92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.omtm.2019.11.016","article-title":"Genome editing in patient iPSCs corrects the most prevalent USH2A mutations and reveals intriguing mutant mRNA expression profiles","volume":"17","author":"Sanjurjo-Soriano","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2025.107638_bib93","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114817","article-title":"Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes","volume":"14","author":"Grotz","year":"2022","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib94","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.omtn.2020.07.036","article-title":"Antisense oligonucleotide- and CRISPR-Cas9-mediated rescue of mRNA splicing for a deep intronic CLRN1 mutation","volume":"21","author":"Panagiotopoulos","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.8.23","article-title":"Reduced expression of VEGF-A in human retinal pigment epithelial cells and human Muller cells following CRISPR-Cas9 ribonucleoprotein-mediated gene disruption","volume":"9","author":"Ameri","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.phrs.2025.107638_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132426","article-title":"cRGD-modified hybrid lipopolymeric nanoplexes for gene editing in the posterior segment of the eye","volume":"271","author":"Sahel","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2025.107638_bib97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtm.2020.01.006","article-title":"Factors impacting efficacy of AAV-mediated CRISPR-based genome editing for treatment of choroidal neovascularization","volume":"17","author":"Chung","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2025.107638_bib98","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","article-title":"Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice","volume":"5","author":"Ling","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.phrs.2025.107638_bib99","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ymthe.2020.09.032","article-title":"Targeted knockout of the Vegfa gene in the retina by subretinal injection of RNP complexes containing Cas9 protein and modified sgRNAs","volume":"29","author":"Holmgaard","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.omtn.2022.04.015","article-title":"CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization","volume":"28","author":"Chung","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib101","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1038\/s41467-022-35640-4","article-title":"Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration","volume":"13","author":"Yin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/nsr\/nwaa033","article-title":"CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.phrs.2025.107638_bib103","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/s41598-023-29014-z","article-title":"CRISPR\/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib104","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/acsabm.0c01465","article-title":"CRISPR-dcas9 optogenetic nanosystem for the blue light-mediated treatment of neovascular lesions","volume":"4","author":"Li","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.phrs.2025.107638_bib105","doi-asserted-by":"crossref","DOI":"10.1089\/crispr.2024.0019","article-title":"Prime editing of vascular endothelial growth factor receptor 2 attenuates angiogenesis in vitro","author":"Ma","year":"2024","journal-title":"Crispr J."},{"key":"10.1016\/j.phrs.2025.107638_bib106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-0716-3255-0_17","article-title":"Genome editing inhibits retinal angiogenesis in a mouse model of oxygen-induced retinopathy","volume":"2678","author":"Wu","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107638_bib107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2018.10.009","article-title":"Long-term effects of in vivo genome editing in the mouse retina using Campylobacter jejuni Cas9 expressed via adeno-associated virus","volume":"27","author":"Jo","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1383","article-title":"Nme(2) Cas9-mediated therapeutic editing in inhibiting angiogenesis after wet age-related macular degeneration onset","volume":"13","author":"Hu","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib109","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1167\/iovs.65.4.43","article-title":"CFH haploinsufficiency and complement alterations in early-onset macular degeneration","volume":"65","author":"Lim","year":"2024","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/hum.2022.079","article-title":"Genome editing of Pik3cd impedes abnormal retinal angiogenesis","volume":"34","author":"Wu","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib111","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.phrs.2025.107638_bib112","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/s41467-024-50050-4","article-title":"CRISPR-CasRx-mediated disruption of Aqp1\/Adrb2\/Rock1\/Rock2 genes reduces intraocular pressure and retinal ganglion cell damage in mice","volume":"15","author":"Yao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101524","article-title":"CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma","author":"Jiang","year":"2024","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib114","first-page":"974","article-title":"Myocilin and glaucoma: A TIGR by the tail?","volume":"118","author":"Johnson","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.phrs.2025.107638_bib115","first-page":"671","article-title":"Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork","volume":"43","author":"Wang","year":"2019","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib116","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1038\/s41598-024-57286-6","article-title":"Lentiviral mediated delivery of CRISPR\/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma","volume":"14","author":"Patil","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib117","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","article-title":"Mouse \u03b3-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells","volume":"40","author":"Wang","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107638_bib118","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.omtn.2023.07.015","article-title":"RGC-specific ATF4 and\/or CHOP deletion rescues glaucomatous neurodegeneration and visual function","volume":"33","author":"Fang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib119","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtn.2023.02.029","article-title":"Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies","volume":"32","author":"Liu","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib120","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.neuron.2022.06.003","article-title":"Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells","volume":"110","author":"Tian","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107638_bib121","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.11.2.8","article-title":"Targeting NECTIN-1 based on CRISPR\/Cas9 system attenuated the herpes simplex virus infection in human corneal epithelial cells in vitro","volume":"11","author":"Li","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.phrs.2025.107638_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108272","article-title":"Corneal myofibroblasts and fibrosis","volume":"201","author":"Wilson","year":"2020","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.phrs.2025.107638_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109654","article-title":"A negative feedback loop centered on SMAD3 expression in transforming growth factor \u03b21-induced corneal myofibroblast differentiation","volume":"236","author":"Tang","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109113","article-title":"Evaluation of CRISPR\/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro","volume":"220","author":"Tripathi","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.phrs.2025.107638_bib125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3390\/antiox9111085","article-title":"SIRT1 activation using CRISPR\/dCas9 promotes regeneration of human corneal endothelial cells through inhibiting senescence","volume":"9","author":"Joo","year":"2020","journal-title":"Antioxid.ants"},{"key":"10.1016\/j.phrs.2025.107638_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107745","article-title":"The potential protective effects of miR-497 on corneal neovascularization are mediated via macrophage through the IL-6\/STAT3\/VEGF signaling pathway","volume":"96","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.107638_bib127","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1167\/iovs.14-16222","article-title":"TCF4 triplet repeat expansion and nuclear RNA foci in Fuchs' endothelial corneal dystrophy","volume":"56","author":"Mootha","year":"2015","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2025.107638_bib128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/tvst.9.9.47","article-title":"Trinucleotide repeat-targeting dCas9 as a therapeutic strategy for Fuchs' endothelial corneal Dystrophy","volume":"9","author":"Rong","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.phrs.2025.107638_bib129","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.omtn.2022.01.005","article-title":"Heterogeneity of human corneal endothelium implicates lncRNA NEAT1 in Fuchs endothelial corneal dystrophy","volume":"27","author":"Wang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib130","first-page":"321","article-title":"Fuchs endothelial corneal dystrophy: current perspectives","author":"Vedana","year":"2016","journal-title":"Clin. Ophthalmol. 10"},{"key":"10.1016\/j.phrs.2025.107638_bib131","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55637","article-title":"Start codon disruption with CRISPR\/Cas9 prevents murine Fuchs' endothelial corneal dystrophy","volume":"10","author":"Uehara","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2025.107638_bib132","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000324079","article-title":"Clinical and basic aspects of gelatinous drop-like corneal dystrophy","volume":"48","author":"Kawasaki","year":"2011","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.phrs.2025.107638_bib133","doi-asserted-by":"crossref","DOI":"10.1111\/tra.12927","article-title":"Rescue of secretion of rare-disease-associated misfolded mutant glycoproteins in UGGT1 knock-out mammalian cells","volume":"25","author":"Tax","year":"2024","journal-title":"Traffic"},{"key":"10.1016\/j.phrs.2025.107638_bib134","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(23)01952-9","article-title":"A new age of precision gene therapy","volume":"403","author":"Schambach","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2025.107638_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5496","article-title":"Quantification of Cas9 binding and cleavage across diverse guide sequences maps landscapes of target engagement","volume":"7","author":"Boyle","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2025.107638_bib136","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.cell.2022.09.026","article-title":"Structural basis for Cas9 off-target activity","volume":"185","author":"Pacesa","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107638_bib137","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1038\/s41467-023-42695-4","article-title":"Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib138","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","article-title":"On- and off-target effects of paired CRISPR-Cas nickase in primary human cells","volume":"32","author":"Klermund","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib140","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41591-022-01848-6","article-title":"Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans","volume":"28","author":"Tang","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107638_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2024.09.027","article-title":"Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes","author":"Sin","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.107638_bib142","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107638_bib143","article-title":"Progress and perspective of CRISPR-Cas9 technology in translational medicine","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2025.107638_bib144","unstructured":"GenScript Biotech, From Concept to Clinic: Navigating the Regulatory Path of CRISPR-based Therapeutics. \u3008https:\/\/www.genscript.com\/navigating-the-regulatory-path-of-crispr-based-therapeutics.html?page_no=\u20091&position_no=\u20091&sensors=search_information\/\u3009, 2024 (Accessed 3 January 2025)."},{"key":"10.1016\/j.phrs.2025.107638_bib145","unstructured":"U.S. Food & Drug Administration, Human Gene Therapy Products Incorporating Human Genome Editing: Guidance for Industry. \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing\/\u3009, 2024 (Accessed 3 January 2025)."},{"key":"10.1016\/j.phrs.2025.107638_bib146","unstructured":"U.S. Food & Drug Administration, Cellular, Tissue, and Gene Therapies Advisory Committee October 31, 2023 Meeting Announcement. \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing\/\u3009, 2023 (Accessed 3 January 2025),"},{"key":"10.1016\/j.phrs.2025.107638_bib147","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1038\/s41467-024-47800-9","article-title":"CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing","volume":"15","author":"Pedrazzoli","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107638_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102366","article-title":"Rationally designed Campylobacter jejuni Cas9 enables efficient gene activation and base editing","volume":"35","author":"Chen","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2025.107638_bib149","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41556-022-00870-7","article-title":"Multiplexed genome regulation in vivo with hyper-efficient Cas12a","volume":"24","author":"Guo","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107638_bib150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12951-023-02044-5","article-title":"Emerging non-viral vectors for gene delivery","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2025.107638_bib151","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.actbio.2019.10.037","article-title":"Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina","volume":"101","author":"Yang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2025.107638_bib152","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1248\/bpb.b22-00452","article-title":"Feasibility study of dendrimer-based TTR-CRISPR pDNA polyplex for ocular amyloidosis in vitro","volume":"45","author":"Inoue","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2025.107638_bib153","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.08.042","article-title":"LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea","volume":"350","author":"Mirjalili Mohanna","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2025.107638_bib154","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2021.06.030","article-title":"In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles","volume":"336","author":"Wang","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2025.107638_bib155","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2025.107638_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109857","article-title":"Efficient stimulation of retinal regeneration from M\u00fcller glia in adult mice using combinations of proneural bHLH transcription factors","volume":"37","author":"Todd","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.107638_bib157","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2020.03.024","article-title":"Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice","volume":"181","author":"Zhou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107638_bib158","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/13816810.2020.1778736","article-title":"Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases","volume":"41","author":"Shah","year":"2020","journal-title":"Ophthalmic Genet"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:25:51Z","timestamp":1745583951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":158,"alternative-id":["S1043661825000635"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107638","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From bench to bedside: Developing CRISPR\/Cas-based therapy for ocular diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107638"}}